Journals / Medeniyet Medical Journal / 2019 / Cilt: 34 - Sayı: 2

Association Between Atherosclerosis and Monocyte/High Density Lipoprotein Ratio in Patients with Familial Mediterranean Fever

Ailevi Akdeniz Ateşi Olan Hastaların Monosit/Yüksek Dansiteli Lipoprotein Oranının Ateroskleroz ile İlişkisi

Pages
194–199
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

High sensitive-CRP was also significantly higher in patients with FMF as compared with controls [6.70 (2.7-15.4) vs. 1.75 (1.0-2.73), p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Familial Mediterranean Fever (FMF) is a chronic autosomal recessive disease involving many organs, and tissues mainly peritoneum and pleural tissues and progresses with febrile episodes.
📊
Key Findings & Data:We aimed to investigate the relationship between atherosclerosis and monocyte/HDL ratio in patients with FMF.Method: A total of 40 patients with FMF [21 female, median age: 37 (27-47)] diagnosed with Tel-Hashomer criteria [21 female, median age: 38 (35-40)] who applied to our clinic were included in the study.
💡
Conclusion & Impact:High sensitive-CRP was also significantly higher in patients with FMF as compared with controls [6.70 (2.7-15.4) vs. 1.75 (1.0-2.73), p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Familial Mediterranean Fever (FMF) is a chronic autosomal recessive disease involving many organs, and tissues mainly peritoneum and pleural tissues and progresses with febrile episodes. In diseases progressing with subclinical inflammation such as FMF along with conventional cardiovascular risk factors oxidative stress, inflammation and endothelial damage can cause cardiovascular diseases. The monocyte/high-density lipoprotein ratio (MHR) may indicate inflammation and oxidative stress due to the proinflammatory effect of the monocytes. We aimed to investigate the relationship between atherosclerosis and monocyte/HDL ratio in patients with FMF.Method: A total of 40 patients with FMF [21 female, median age: 37 (27-47)] diagnosed with Tel-Hashomer criteria [21 female, median age: 38 (35-40)] who applied to our clinic were included in the study. As a control group age-, and gender-matched 35 healthy volunteer individuals [21 women, median age: 38 (35-40)] were also included in the study and 35 controls. Monocyte/HDL ratio, and coronary flow reserves were evaluated as well.Results: Demographic characteristics did not differ between both groups. Monocyte count (0.55±0.15 vs. 0.46±0.14; p:0.013) and monocyte/HDL ratio (0.014 (0.010-0.017) vs. 0.010 (0.008-0.013); p: 0.003) were significantly higher in patients than controls. High sensitive-CRP was also significantly higher in patients with FMF as compared with controls [6.70 (2.7-15.4) vs. 1.75 (1.0-2.73), p

Özet

Amaç: Ailevi Akdeniz Ateşi (AAA) başta periton ve plevral dokular olmak üzere birçok doku ve organı etkileyen ataklar halinde giden kronik inflamatuvar otozomal resesif bir hastalıktır. AAA gibi subklinik inflamasyonla giden hastalıklarda klasik kardiovasküler risk faktörlerinin yanı sıra oksidatif stres, inflamasyon ve endotelyal hasar da kardiyovasküler hastalık oluşumuna neden olabilmektedir. Monosit/yüksek dansiteli lipoprotein oranı inflamasyon ve oksidatif stresi monositlerin proenflamatuvar etkileri üzerinden gösterebilmektedir. Bu çalışmamızda, AAA hastalarında ateroskleroz ve monosit/HDL oranını arasındaki olası bir ilişkiyi araştırdık. Yöntem: Çalışmaya Haziran 2006 ile Ağustos 2018 tarihleri arasında kliniğimize başvurmuş, çalışmaya dahil edilme kriterlerini taşıyan Tel-Hashomer kriterleri ile tanı konmuş 40 AAA hastası [21 kadın, medyan yaş: 37 (27-47)] alındı. Kontrol grubu olarak yaş ve cinsiyet yönünden benzer 35 sağlıklı gönüllü [21 kadın, medyan yaş: 38 (35-40)] alındı. Monosit/HDL oranı yanı sıra koroner akım rezervleri de değerlendirildi. Bulgular: Gruplar arasında demografik özellikler açısından fark yoktu. Monosit sayısı ve monosit/HDL oranı hastalarda kontrollerden daha yüksekti [(0,55±0,15 vs 0,46±0,14; p:0,013) ve (0,014 (0,010-0,017) vs 0,010 (0,008-0,013); p:0,003, sırasıyla]. Yüksek sensitiviteli C reaktif protein düzeyi de hastalarda daha yüksek olarak bulundu [6,70 (2,7-15,4) vs, 1,75 (1,0-2,73), p

🔖

Cite This Article

CALISKAN, M., CAKILLI, O. T., YILMAZ, Y., CALISKAN, Z. B. (2022). Association Between Atherosclerosis and Monocyte/High Density Lipoprotein Ratio in Patients with Familial Mediterranean Fever. Medeniyet Medical Journal, Cilt: 34 - Sayı: 2, 194–199. https://ajindex.com/articles/579265

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever a survey of 470 cases and review of the literature. Am J Med. 1967
  2. [CrossRef] 2. Lachmann HJ, Sengul B, Yavuzsen TU et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006
  3. [CrossRef] 3. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 2002
  4. [CrossRef] 4. Musabak U, Sengul A, Oktenli C et al. Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol. 2004
  5. [CrossRef] 5. Ozen S, Bakkaloglu A, Yilmaz E et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol. 2003
  6. Tunca M, Kirkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN. Acute phase response and evolution of familial Mediterranean fever. Lancet. 1999
  7. [CrossRef] 7. Serrano R, Martínez MA, Andrés A, Morales JM, Samartin R. Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis. Histopathology. 1998
  8. [CrossRef] 8. Caliskan M, Gullu H, Yilmaz S,et al. Impaired coronary microvascular function in familial Mediterranean fever. Atherosclerosis. 2007
  9. [CrossRef] 9. Gan LM, Wikstrom J, Fritsche-Danielson R. Coronary flow reserve from mouse to man-from mechanistic understanding to future interventions. J Cardiovasc Transl Res. 2013
  10. [CrossRef] 10. Turkmen K, Oflaz H, Uslu B, et al. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol. 2008
  11. [CrossRef] 11. van Eijk IC, Peters MJ, Serné EH, et al. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis. 2009
  12. [CrossRef] 12. Karatas¸ MB, Çanga Y, Özcan KS, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016
  13. [CrossRef] 13. Kundi H, Kiziltunc E, Cetin M, et al. Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease. Herz. 2016
  14. [CrossRef] 14. Kanbay M, So